Hyderabad, Telangana, India:
Mr. K.T. Rama Rao, Hon’ble Minister for Industries & Commerce, IT, MA, and UD, Government of Telangana, inaugurated the state-of-the-art facility of GV Safety Assessment Platform (GVSAP), at Genome Valley on 18th October. Mr. Jayesh Ranjan, Principal Secretary (IT, E&C), Govt. of Telangana, and Mr. Shakthi Nagappan, Director (LS), Government of Telangana had been additionally current through the occasion.
GVSAP is the Preclinical providers vertical of GV Research Platform (GVRP) concerned in industrial breeding of Specific Pathogen Free (SPF) analysis fashions and preclinical testing. Spread throughout 28,000 sq.ft., the Class 100,000 analysis facility is supplied with the most recent in clean-room know-how and sturdy Building Management System.
GVSAP is the approved Breeding and Distribution companions in India for Envigo RMS LLC, a US-based world chief in analysis fashions and associated providers. This partnership will help Biomedical firms in India to domestically supply premier top quality Specific Pathogen Free (SPF) Envigo branded analysis fashions in accelerating their analysis applications. Additionally, GVSAP may even prolong Preclinical R&D providers like toxicology, pharmacology, and bioanalytical targeted on each in-vitro and in-vivo analysis.
Mr. K.T. Rama Rao, Hon’ble Minister for Industries & Commerce, IT, MA, and UD, Government of Telangana, stated, “I’m glad to welcome GVRP and Envigo in Genome Valley. Housing the National Animal Resource Facility and companies like GVRP, Genome Valley is now the epicenter for preclinical and clinical research, thereby emerging as the most attractive innovation destination for biomedical companies in the Country.”
Mr S.P. Reddy, Managing Director, GVRP, stated, “The process of reinventing India from being a world-leading generics exporter to delivering novel therapies is taking rapid strides. GVRP is our effort in the same direction to pave the way for accelerated Life sciences innovation. This facility is the first step in building a robust and efficient solution that will make a difference to the Biomedical community in enabling them bring lifesaving therapies faster to the market.”
The present ecosystem depends closely on the import of SPF fashions from worldwide suppliers to satisfy their preclinical analysis calls for. Considering rising implications of analysis fashions in oncology, continual infectious illnesses, and for vaccine batch launch and efficiency testing, the import of those fashions from worldwide suppliers instantly provides to the R&D price.
Mr. Kalyan Korisapati, Co-Founder and CEO, GVRP, stated, “GVSAP places itself uniquely in the market by bringing capabilities of both in-house SPF research model breeding as well as preclinical testing. Our partnership with Envigo, coupled with flagship research facility designed in compliance with international standards such OECD-GLP and AAALACi, is aimed at providing best-in-class support for Life sciences innovation.”
GV Safety Assessment Platform (GVSAP), targeted on offering a variety of preclinical analysis services and products is a subsidiary of GV Research Platform (“GVRP”). Founded in 2020 by a workforce of business specialists, GVRP is designed as an environment friendly various to deal with gaps within the conventional biology and chemistry R&D outsourcing fashions. GVRP has made strides in attaining its imaginative and prescient of enabling environment friendly and reasonably priced innovation by differentiated and customised R&D options.
For extra particulars, please go to www.gvrp.in
